BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0013
+0.0001 (8.33%)
At close: Nov 9, 2026
BioAdaptives Employees
BioAdaptives had 1 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year. That makes BioAdaptives the 44,042nd largest employer in the world and 7,312th in the United States.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$25,561
Profits / Employee
-$1,163,844
Market Cap
256.01K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | 0 | - | 1 | 0 |
| Mar 31, 2026 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Jun 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Mar 31, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Sep 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Jun 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Mar 31, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Dec 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Sep 30, 2023 | 6 | 0 | - | 3 | 3 |
| Jun 30, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Mar 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Dec 31, 2022 | 7 | 0 | - | 3 | 4 |
| Sep 30, 2022 | 6 | -1 | -14.29% | 3 | 3 |
| Jun 30, 2022 | 7 | - | - | 3 | 4 |
| Mar 31, 2022 | 7 | - | - | 3 | 4 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
BioAdaptives News
- 6 weeks ago - BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video - Accesswire
- 2 months ago - BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress - Accesswire
- 2 months ago - UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM) - Accesswire
- 2 months ago - BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update - Accesswire
- 3 months ago - BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal - Accesswire
- 3 months ago - BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula - Accesswire
- 3 months ago - BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor - Accesswire
- 3 months ago - BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform - Accesswire